Ocular Therapeutix

Marketing

Ocular Therapeutix sharpens focus with retina-centric rebrand

Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli.

Nick Paul Taylor Jun 27, 2025 10:05am

Eye Chart Eye Exam

FDA clears Ocular's Dextenza for eye itching from allergies

Oct 12, 2021 10:20am

regeneron

Regeneron scraps sustained-release Eylea alliance with Ocular

Aug 10, 2021 8:45am

Eye Ocular Therapeutix procedure

Ocular Therapeutix crosses the finish line with eye treatment

Dec 4, 2018 11:15am

Eye punctum

Ocular Therapeutix gets second CRL for eye drug

Jul 12, 2017 11:08am

John Hovanesian

Eye doc calls for more sustained drug delivery systems for ocular surfaces

Sep 13, 2016 12:38am